In multiple myeloma, for example, the inhibition of IL-6 receptor signaling through STAT3 was shown to induce apoptosis, an indication that IL-6-mediated STAT3 activation contributes to the pathogenesis of multiple myeloma by increasing the survival potential of tumor cells [41]. This evidence concerns the gene STAT3 and neoplasm.